California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin ...
We tapped some of Palm Beach’s most stylish men to don Lilly Pulitzer's new threads and dish on their own sartorial ...
Here's a rundown of some of the multibillion-dollar spending pledges made by companies since President Trump took office. Apple: The iPhone maker pledged to spend more than $500 billion over four ...
By Nqobile Dludla JOHANNESBURG (Reuters) -Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it ...
People who land in the ER after using hallucinogens are more than twice as likely to die in a handful of years, a new study ...
The lifetime risk of dementia after age 55 is about 42%, according to a recent study published in the journal Nature Medicine. Around 1 million adults in the U.S. are projected to develop dementia ...
Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the Federal Food and Drug Administration ...
President Trump’s tariffs on top U.S. trading partners are set to take effect in coming days. Investors have been trying to ...
AbbVie on Monday jumped into the hot weight-loss space, looking to gain ground on its Big Pharma peers, with a licensing deal ...
Rosacea treatment is a marathon — not a sprint — and there’s a need for increased emphasis on a patient-centric approach to ...
AbbVie is jumping into the burgeoning obesity field, striking a license agreement with Gubra that is potentially worth more than $2 billion to the Danish drug-discovery and contract-research-services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results